To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FGFRL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
289 supporting clones for gene FGFRL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF279689   .a 1 to 1565 1 to 1565 P372Q tiling clone,   1565/1565
(100 %)
3 diff
(99.9 %id)
AI245701 Kidney .a 1 to 486 1 to 486     Submitted on the opposite strand 486/486
(100 %)
6 diff
(98.8 %id)
NM_001004358.1   .a 1 to 3097 1 to 3097 exact RefSeq, AAA   3097/3097
(100 %)
0 diff
(100 %id)
NM_021923.3   .a 11 to 3097 1 to 3087   RefSeq, AAA   3087/3087
(100 %)
0 diff
(100 %id)
AY358303   .b 1 to 2630 1 to 2630 exact tiling clone,   2630/3402
(77 %)
8 diff
(99.8 %id)
NM_001004356.2   .b 1 to 3215 1 to 3215 exact RefSeq,   3215/3215
(100 %)
0 diff
(100 %id)
BU529098 epidermoid carcinoma, cell line, lung .b 86 to 624 1 to 545   tiling clone,   545/1240
(43 %)
9 diff
(99.3 %id)
DA512967 brain .b 440 to 950 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
BC013955 Kidney, renal cell adenocarcinoma .b 565 to 3214 1 to 2649   available from MGC, AAA   2649/2649
(100 %)
5 diff
(99.9 %id)
BC015228 Pancreas, epithelioid carcinoma .b 717 to 3214 1 to 2498   tiling clone, available from MGC, AAA   2498/2498
(100 %)
0 diff
(100 %id)
BM561429 duodenal adenocarcinoma, cell line, small intestine .b 844 to 1576 34 to 775       742/1076
(68 %)
24 diff
(97.8 %id)
CX873685 embryonic stem .b 853 to 1627 1 to 775       775/775
(100 %)
0 diff
(100 %id)
TI_1948225041   .b 1023 to 1663 769 to 123       647/1290
(50 %)
20 diff
(98.5 %id)
AW845240 colon .b 1057 to 1717 1 to 660       660/660
(100 %)
6 diff
(99.1 %id)
DA023545   .b 1060 to 1629 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BY797788 eye .b 1061 to 1664 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BG387406 adenocarcinoma cell line, colon .b 1068 to 1630 1 to 567       567/874
(64 %)
24 diff
(97.3 %id)
BE780737 eye, retinoblastoma .b 1076 to 1725 1 to 644       644/951
(67 %)
11 diff
(98.9 %id)
BQ227637 epithelioid carcinoma, Pancreas .b 1189 to 1998 1 to 816       816/930
(87 %)
13 diff
(98.7 %id)
AU280034   .b 1206 to 1779 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
CN388359 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1212 to 1729 1 to 518       518/518
(100 %)
0 diff
(100 %id)
AK022597   .b 1216 to 3214 1 to 1999   available from FLJ,   1999/1999
(100 %)
0 diff
(100 %id)
DB316552 brain .b 2758 to 3214 458 to 1       458/468
(97 %)
5 diff
(99.0 %id)
DA017345 adrenal gland .c -10 to 375 2 to 387   capped   386/386
(100 %)
0 diff
(100 %id)
DA300854 hippocampus .c -10 to 567 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
AK314365 brain .c -8 to 1656 1 to 1665 exact tiling clone,   1665/1665
(100 %)
2 diff
(99.9 %id)
DA212359 brain .c 1 to 482 10 to 490   capped   489/489
(100 %)
3 diff
(99.4 %id)
DA573943   .c 1 to 567 3 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA189526 amygdala .c 1 to 596 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA226457 brain .c 5 to 512 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DA395687 thalamus .c 5 to 599 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
AJ277437 cartilage .c 120 to 3199 1 to 3080 P362Q tiling clone,   3080/3080
(100 %)
6 diff
(99.9 %id)
AK225486 thyroid .c 148 to 1997 1 to 1849   tiling clone,   1851/1849
(100 %)
1 diff
(100.0 %id)
DB217919 trachea .d 1 to 334 2 to 335   tiling clone, capped   334/335
(99 %)
4 diff
(98.9 %id)
BM560249 brain, medulla .d 455 to 1205 7 to 762   tiling clone,   756/1112
(67 %)
23 diff
(98.0 %id)
BC036769 Brain, adult medulla .d 459 to 3678 1 to 3220 exact tiling clone, available from MGC, AAA   3220/3220
(100 %)
0 diff
(100 %id)
BF968611 adrenal cortex carcinoma, cell line, adrenal gland .d 609 to 1294 1 to 688       688/762
(90 %)
13 diff
(98.3 %id)
CV030908 mixed .d 620 to 1232 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
TI_1948135426   .d 620 to 1314 131 to 822       692/1364
(50 %)
51 diff
(96.3 %id)
TI_1948136136   .d 620 to 1124 126 to 636       511/1376
(37 %)
28 diff
(98.0 %id)
TI_1948136137   .d 620 to 1261 144 to 794       651/1483
(43 %)
42 diff
(97.2 %id)
TI_1948136487   .d 621 to 1153 126 to 662       537/1420
(37 %)
26 diff
(98.2 %id)
BP265809 thyroid .d 626 to 1208 1 to 582       584/582
(100 %)
1 diff
(99.9 %id)
BQ689625 ductal carcinoma, cell line, Pancreas .d 643 to 1506 1 to 871       871/895
(97 %)
40 diff
(95.6 %id)
BI825023 pooled brain, lung, testis .d 694 to 1315 33 to 661       629/661
(95 %)
17 diff
(97.5 %id)
TI_57198725   .d 694 to 1315 33 to 661       629/661
(95 %)
17 diff
(97.5 %id)
BF765462 colon_est .d 702 to 1081 1 to 380       380/380
(100 %)
3 diff
(99.3 %id)
BP254943 Kidney .d 734 to 1297 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BF765880 colon_est .d 769 to 1185 418 to 1     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
BG331236 large cell carcinoma, lung .d 806 to 1565 1 to 759       757/983
(77 %)
30 diff
(97.0 %id)
BQ954827 large cell carcinoma, lung .d 808 to 1658 1 to 872       872/877
(99 %)
65 diff
(92.6 %id)
BG422503 Kidney, renal cell adenocarcinoma .d 851 to 1563 1 to 709       709/945
(75 %)
27 diff
(97.2 %id)
DA548646   .d 914 to 1491 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
BQ924530 epidermoid carcinoma, cell line, lung .d 915 to 1823 1 to 914       914/925
(98 %)
19 diff
(98.0 %id)
BE272724 Kidney, renal cell adenocarcinoma .d 918 to 1527 1 to 652       616/653
(94 %)
62 diff
(90.6 %id)
CO403921 Chondrosarcoma Lung Metastasis cell lines, lung .d 929 to 1652 46 to 759       714/852
(83 %)
20 diff
(97.7 %id)
BM045705 carcinoma, cell line, Prostate .d 948 to 1739 1 to 867       620/867
(71 %)
58 diff
(93.4 %id)
BM046876 carcinoma, cell line, Prostate .d 949 to 1691 1 to 739       739/742
(99 %)
11 diff
(98.6 %id)
BU528897 epidermoid carcinoma, cell line, lung .d 951 to 1827 1 to 885       885/886
(99 %)
14 diff
(98.5 %id)
BM561628 duodenal adenocarcinoma, cell line, small intestine .d 972 to 1956 1 to 987       987/999
(98 %)
18 diff
(98.2 %id)
CO247004 Chondrosarcoma Lung Metastasis cell lines, lung .d 1008 to 1590 38 to 610       573/754
(75 %)
19 diff
(97.5 %id)
BP219084 caudate nucleus .d 1048 to 1630 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BF970020 adrenal cortex carcinoma, cell line, adrenal gland .d 1069 to 1768 1 to 695       695/784
(88 %)
31 diff
(96.1 %id)
DA497644 brain .d 1080 to 1629 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
EL735920 mixed .d 1082 to 1719 1 to 638       638/641
(99 %)
5 diff
(99.3 %id)
TI_1948224411   .d 1082 to 1932 137 to 989       853/1343
(63 %)
31 diff
(97.7 %id)
TI_1948224728   .d 1082 to 1953 127 to 1007       881/1461
(60 %)
52 diff
(96.5 %id)
TI_1948225038   .d 1082 to 1883 127 to 939       811/1431
(56 %)
41 diff
(97.2 %id)
TI_1948225039   .d 1082 to 1689 132 to 746       615/1137
(54 %)
17 diff
(98.6 %id)
TI_1948225364   .d 1082 to 1931 128 to 977       850/1398
(60 %)
50 diff
(96.5 %id)
TI_1948225365   .d 1082 to 1627 105 to 656       552/1119
(49 %)
34 diff
(97.0 %id)
BG326224 Kidney, renal cell adenocarcinoma .d 1098 to 1832 1 to 726       726/727
(99 %)
11 diff
(98.5 %id)
BG423479 Kidney, renal cell adenocarcinoma .d 1169 to 1945 1 to 782       782/957
(81 %)
42 diff
(95.7 %id)
BE905441 epithelioid carcinoma, Pancreas .d 1208 to 1880 1 to 720   available from MGC,   663/723
(91 %)
70 diff
(90.4 %id)
BF307860 muscle, rhabdomyosarcoma .d 1228 to 1880 1 to 655       655/981
(66 %)
25 diff
(97.5 %id)
TI_1948224413   .d 1338 to 2133 920 to 128       793/1145
(69 %)
20 diff
(98.3 %id)
BQ900887 eye, normal pigmented retinal epithelium .d 1440 to 2338 1 to 903       903/906
(99 %)
32 diff
(96.5 %id)
TI_1948225040   .d 1443 to 2133 822 to 122       701/1305
(53 %)
32 diff
(97.6 %id)
BP203406 coronary artery .d 1453 to 2024 1 to 572       572/572
(100 %)
0 diff
(100 %id)
TI_1948225367   .d 1454 to 2133 805 to 124       682/1197
(56 %)
12 diff
(99.0 %id)
BF984116 duodenal adenocarcinoma, cell line, small intestine .d 1477 to 2209 1 to 727       727/936
(77 %)
24 diff
(97.5 %id)
EC494436 Prostate .d 1639 to 1743 105 to 1       105/105
(100 %)
0 diff
(100 %id)
EC519424 Prostate .d 1659 to 1761 109 to 7       103/109
(94 %)
0 diff
(100 %id)
EC523754 Prostate .d 1697 to 1762 65 to 1       65/96
(67 %)
1 diff
(99.0 %id)
BM903664 ovary (pool of 3) .d 1703 to 2500 8 to 811       804/1053
(76 %)
17 diff
(98.4 %id)
EC530341 Prostate .d 1710 to 1803 95 to 3       93/97
(95 %)
0 diff
(100 %id)
DA941753 Spleen .d 1714 to 2271 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BM478437 eye, retinoblastoma .d 1751 to 2404 1 to 656       656/1162
(56 %)
17 diff
(98.6 %id)
BQ879072 dorsal root ganglia .d 1751 to 2583 1 to 840       840/841
(99 %)
11 diff
(98.7 %id)
BE392778 endometrium, adenocarcinoma cell line, uterus .d 1820 to 2494 1 to 690       690/699
(98 %)
33 diff
(95.3 %id)
EC460820 Prostate .d 1899 to 2001 105 to 4       102/105
(97 %)
0 diff
(100 %id)
EC486553 Prostate .d 1900 to 2000 102 to 3       100/102
(98 %)
0 diff
(100 %id)
BE273980 Kidney, renal cell adenocarcinoma .d 1908 to 2573 1 to 668       668/668
(100 %)
9 diff
(98.7 %id)
BU169131 ductal carcinoma, cell line, Pancreas .d 1962 to 2464 1 to 508       508/724
(70 %)
15 diff
(98.0 %id)
DA912015   .d 1969 to 2546 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
BG828377 muscle, rhabdomyosarcoma .d 1985 to 2573 1 to 591       591/591
(100 %)
7 diff
(98.9 %id)
BG423273 Kidney, renal cell adenocarcinoma .d 2032 to 2715 1 to 687       687/687
(100 %)
12 diff
(98.3 %id)
AV684577 hepatocellular carcinoma .d 2046 to 2788 1 to 735       735/819
(89 %)
43 diff
(94.8 %id)
BF933621 nervous_tumor .d 2055 to 2266 236 to 23     Submitted on the opposite strand 214/236
(90 %)
0 diff
(100 %id)
BQ953203 epidermoid carcinoma, cell line, lung .d 2059 to 2760 705 to 1     Submitted on the opposite strand 705/909
(77 %)
3 diff
(99.7 %id)
BQ952255 epidermoid carcinoma, cell line, lung .d 2062 to 2966 1 to 912       912/959
(95 %)
19 diff
(98.1 %id)
BG998840 head_neck .d 2064 to 2377 435 to 123       313/435
(71 %)
0 diff
(100 %id)
EC447637 Prostate .d 2065 to 2152 1 to 88       88/88
(100 %)
0 diff
(100 %id)
EC490096 Prostate .d 2065 to 2152 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
BG036629 adenocarcinoma, cell line, Prostate .d 2069 to 2828 1 to 771       771/876
(88 %)
30 diff
(96.6 %id)
BF792014 adrenal cortex carcinoma, cell line, adrenal gland .d 2093 to 2759 1 to 668       668/912
(73 %)
8 diff
(99.2 %id)
BE777873 eye, retinoblastoma .d 2122 to 2783 1 to 672       672/672
(100 %)
20 diff
(97.1 %id)
EC461824 Prostate .d 2124 to 2222 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
EC560178 Prostate .d 2128 to 2233 1 to 105       105/105
(100 %)
6 diff
(94.3 %id)
EC478043 Prostate .d 2129 to 2233 1 to 102       102/102
(100 %)
5 diff
(95.1 %id)
EC575141 Prostate .d 2130 to 2222 1 to 92       92/101
(91 %)
2 diff
(98.1 %id)
BU956107 adenocarcinoma, cell line, breast .d 2134 to 2982 1 to 854       854/888
(96 %)
13 diff
(98.6 %id)
BQ323578 colon_ins .d 2146 to 2411 13 to 280       268/290
(92 %)
22 diff
(92.5 %id)
BG170021 hypernephroma, cell line, Kidney .d 2147 to 2635 1 to 513       513/775
(66 %)
38 diff
(95.1 %id)
BE745264 adenocarcinoma cell line, ovary .d 2155 to 2907 1 to 759       759/1224
(62 %)
21 diff
(98.3 %id)
AW848212 colon .d 2160 to 2445 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
BI052774 placenta_normal .d 2161 to 2456 1 to 297       297/297
(100 %)
6 diff
(98.0 %id)
BU180774 epithelioid carcinoma, Pancreas .d 2166 to 2743 1 to 592       592/1036
(57 %)
24 diff
(97.7 %id)
AW411524 muscle, rhabdomyosarcoma .d 2180 to 2864 1 to 685       685/685
(100 %)
6 diff
(99.2 %id)
EC582046 Prostate .d 2188 to 2281 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
BU174693 ductal carcinoma, cell line, Pancreas .d 2195 to 2795 1 to 603       603/1088
(55 %)
22 diff
(98.0 %id)
BQ685083 ductal carcinoma, cell line, Pancreas .d 2195 to 3097 1 to 906       906/907
(99 %)
6 diff
(99.4 %id)
BQ311604 breast_normal .d 2211 to 2430 85 to 304       220/304
(72 %)
6 diff
(98.1 %id)
EC555838 Prostate .d 2212 to 2295 1 to 82       82/82
(100 %)
2 diff
(97.6 %id)
EC479390 Prostate .d 2213 to 2281 15 to 83       69/83
(83 %)
7 diff
(91.6 %id)
EC507808 Prostate .d 2213 to 2305 1 to 89       89/89
(100 %)
6 diff
(93.3 %id)
BF807612 colon_ins .d 2216 to 2339 132 to 11     Submitted on the opposite strand 122/132
(92 %)
0 diff
(100 %id)
BF799562 colon_ins .d 2224 to 2462 15 to 261       247/265
(93 %)
16 diff
(94.0 %id)
EC505963 Prostate .d 2224 to 2313 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
BG332879 large cell carcinoma, lung .d 2238 to 2963 1 to 735       735/735
(100 %)
15 diff
(98.0 %id)
EC508321 Prostate .d 2240 to 2321 11 to 93       83/93
(89 %)
6 diff
(93.6 %id)
EC545494 Prostate .d 2240 to 2320 15 to 96       82/96
(85 %)
6 diff
(93.8 %id)
EC563008 Prostate .d 2243 to 2313 17 to 87       71/87
(81 %)
6 diff
(93.2 %id)
BF980548 duodenal adenocarcinoma, cell line, small intestine .d 2243 to 2872 42 to 675       634/1122
(56 %)
10 diff
(99.2 %id)
BM806988 duodenal adenocarcinoma, cell line, small intestine .d 2245 to 3184 1 to 947       947/989
(95 %)
10 diff
(99.0 %id)
CF265070 Brain glioblastoma .d 2254 to 2855 1 to 603       603/623
(96 %)
5 diff
(99.2 %id)
EC576821 Prostate .d 2259 to 2339 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
EC584714 Prostate .d 2260 to 2341 1 to 80       80/80
(100 %)
1 diff
(98.8 %id)
EC490866 Prostate .d 2262 to 2339 1 to 78       78/78
(100 %)
2 diff
(97.5 %id)
EC536563 Prostate .d 2264 to 2342 3 to 80       78/80
(97 %)
6 diff
(92.5 %id)
EC537107 Prostate .d 2265 to 2342 9 to 85       77/85
(90 %)
9 diff
(89.5 %id)
BG011157 placenta_normal .d 2267 to 2442 176 to 1       176/176
(100 %)
3 diff
(98.3 %id)
EC510733 Prostate .d 2269 to 2346 1 to 78       78/78
(100 %)
2 diff
(97.5 %id)
EC496427 Prostate .d 2271 to 2346 1 to 76       76/76
(100 %)
0 diff
(100 %id)
EC510086 Prostate .d 2271 to 2346 1 to 76       76/76
(100 %)
0 diff
(100 %id)
BE746024 adenocarcinoma cell line, ovary .d 2274 to 3074 1 to 812       812/910
(89 %)
19 diff
(98.0 %id)
EC578975 Prostate .d 2275 to 2346 9 to 81       73/81
(90 %)
6 diff
(92.6 %id)
EC583363 Prostate .d 2275 to 2346 8 to 79       72/79
(91 %)
6 diff
(92.5 %id)
BE176556 head_neck .d 2286 to 2842 8 to 576       569/585
(97 %)
21 diff
(96.5 %id)
BF969458 adrenal cortex carcinoma, cell line, adrenal gland .d 2305 to 3014 1 to 721       721/944
(76 %)
61 diff
(93.6 %id)
BG821810 adenocarcinoma cell line, colon .d 2325 to 2398 561 to 639       620/840
(73 %)
55 diff
(93.5 %id)
BC002537 Ovary, adenocarcinoma .d 2343 to 3677 1 to 1335   available from MGC, AAA   1335/1335
(100 %)
0 diff
(100 %id)
BE272083 adenocarcinoma cell line, ovary .d 2362 to 3045 1 to 682   available from MGC,   682/694
(98 %)
7 diff
(99.0 %id)
BF305985 muscle, rhabdomyosarcoma .d 2405 to 3171 1 to 767       767/978
(78 %)
20 diff
(98.0 %id)
BF855709 prostate_normal .d 2417 to 2764 9 to 359       351/359
(97 %)
6 diff
(98.4 %id)
BE898179 melanotic melanoma, skin .d 2424 to 3045 36 to 664       629/829
(75 %)
6 diff
(99.3 %id)
AA442297   .d 2431 to 2871 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
BF850283 lung_normal .d 2434 to 2810 395 to 19     Submitted on the opposite strand 377/395
(95 %)
0 diff
(100 %id)
CD517805 White Matter .d 2434 to 3148 83 to 803       721/1044
(69 %)
24 diff
(97.8 %id)
BG254594 adenocarcinoma, cell line, Prostate .d 2444 to 3112 3 to 688       686/774
(88 %)
6 diff
(99.3 %id)
BG748734 eye, normal pigmented retinal epithelium .d 2451 to 3090 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
BF803784 colon_ins .d 2452 to 2776 27 to 353       327/362
(90 %)
6 diff
(98.4 %id)
AA434362   .d 2469 to 2708 1 to 241       241/241
(100 %)
1 diff
(99.6 %id)
BG927569 cartilage .d 2482 to 3100 88 to 708       621/647
(95 %)
5 diff
(99.3 %id)
EC579639 Prostate .d 2493 to 2570 1 to 79       79/80
(98 %)
2 diff
(97.5 %id)
AI907299 breast .d 2506 to 3002 488 to 2       487/588
(82 %)
0 diff
(100 %id)
AA558517 Prostate, prostatic intraepithelial neoplasia - highgrade .d 2512 to 2799 1 to 284       284/284
(100 %)
5 diff
(98.3 %id)
AI907302 breast .d 2536 to 3002 463 to 2       462/468
(98 %)
0 diff
(100 %id)
EC581579 Prostate .d 2567 to 2648 82 to 1       82/82
(100 %)
0 diff
(100 %id)
AI834236 head_neck .d 2588 to 2770 183 to 1       183/183
(100 %)
5 diff
(97.3 %id)
CN422645 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 2593 to 3014 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BG005738 placenta_normal .d 2597 to 2900 313 to 11       303/313
(96 %)
0 diff
(100 %id)
BF741455 bocio_tumor .d 2599 to 2831 5 to 233       229/233
(98 %)
12 diff
(94.9 %id)
BE378421 endometrium, adenocarcinoma cell line, uterus .d 2623 to 3316 1 to 685       685/753
(90 %)
21 diff
(97.3 %id)
BF340012 brain, glioblastoma with EGFR amplification .d 2663 to 3277 12 to 621       610/974
(62 %)
14 diff
(98.6 %id)
TI_154126602   .d 2684 to 3684 1071 to 86   AAA   986/986
(100 %)
33 diff
(96.7 %id)
BI009072 kidney_tumor .d 2700 to 2914 221 to 7       215/221
(97 %)
0 diff
(100 %id)
BG953111 colon .d 2707 to 3211 506 to 3       504/507
(99 %)
0 diff
(100 %id)
BG982116 colon_normal .d 2750 to 3197 451 to 3       449/451
(99 %)
0 diff
(100 %id)
BG982122 colon_normal .d 2767 to 3193 427 to 1       427/427
(100 %)
0 diff
(100 %id)
BF033645 adenocarcinoma, ovary .d 2774 to 3449 1 to 673       673/837
(80 %)
22 diff
(97.4 %id)
BG981162 colon_normal .d 2793 to 3215 421 to 1       421/421
(100 %)
6 diff
(98.6 %id)
BF741442 bocio_tumor .d 2801 to 2985 183 to 1     Submitted on the opposite strand 183/183
(100 %)
4 diff
(97.9 %id)
BU169794 large cell carcinoma, lung .d 2802 to 3612 1 to 817       817/906
(90 %)
17 diff
(98.2 %id)
BQ367538 placenta_normal .d 2822 to 3236 422 to 7       416/423
(98 %)
0 diff
(100 %id)
BQ351224 head_neck .d 2825 to 3003 9 to 190       182/193
(94 %)
11 diff
(94.4 %id)
BQ427989 melanotic melanoma, skin .d 2852 to 3223 510 to 883       851/883
(96 %)
31 diff
(96.5 %id)
CX785563 human embryonic stem cells .d 2852 to 3352 316 to 816       718/816
(87 %)
46 diff
(94.4 %id)
BG981165 colon_normal .d 2860 to 3230 370 to 1       370/370
(100 %)
6 diff
(98.4 %id)
CD559645 mixed .d 2863 to 3302 468 to 31     Submitted on the opposite strand 438/470
(93 %)
0 diff
(100 %id)
CD559490 mixed .d 2866 to 3302 21 to 456       436/467
(93 %)
6 diff
(98.8 %id)
BM771036 Ascites, stomach .d 2872 to 3354 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
BM756684 Ascites, stomach .d 2873 to 3183 1 to 311       311/311
(100 %)
0 diff
(100 %id)
BM746883 Ascites, stomach .d 2873 to 3484 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BM770668 Ascites, stomach .d 2873 to 3572 1 to 700       700/700
(100 %)
0 diff
(100 %id)
FN093745 breast carcinoma .d 2875 to 2953 80 to 1     Submitted on the opposite strand 80/80
(100 %)
1 diff
(98.8 %id)
BQ182177 Knee, Osteoarthritic Cartilage .d 2887 to 3684 815 to 19   AAA   797/797
(100 %)
3 diff
(99.7 %id)
EC571019 Prostate .d 2903 to 2969 1 to 67       67/67
(100 %)
2 diff
(97.1 %id)
EC513871 Prostate .d 2911 to 2975 11 to 75       65/75
(86 %)
6 diff
(92.0 %id)
TI_154041643   .d 2912 to 3677 841 to 75   AAA   767/942
(81 %)
2 diff
(99.8 %id)
CA416621 Chondrosarcoma Cell line .d 2916 to 3684 786 to 19   AAA   768/768
(100 %)
1 diff
(99.9 %id)
BQ771903 Chondrosarcoma Grade II, Left Pelvis .d 2917 to 3684 785 to 19   AAA   767/767
(100 %)
1 diff
(99.9 %id)
BE873767 large cell carcinoma, undifferentiated, lung .d 2924 to 3572 1 to 639       639/913
(69 %)
12 diff
(98.7 %id)
BQ000420 Fibrosarcoma .d 2926 to 3671 765 to 19   AAA   747/747
(100 %)
1 diff
(99.9 %id)
EC508103 Prostate .d 2930 to 3012 1 to 84       84/84
(100 %)
5 diff
(94.1 %id)
BP273737   .d 2930 to 3488 1 to 559       559/559
(100 %)
7 diff
(98.8 %id)
TI_154123654   .d 2930 to 3679 839 to 87   AAA   753/967
(77 %)
35 diff
(96.4 %id)
AK000530   .d 2933 to 3671 1 to 739   available from FLJ, AAA   739/739
(100 %)
1 diff
(99.9 %id)
EC462934 Prostate .d 2933 to 3012 1 to 80       80/80
(100 %)
1 diff
(98.8 %id)
EC478027 Prostate .d 2934 to 3012 1 to 79       79/79
(100 %)
0 diff
(100 %id)
EC478941 Prostate .d 2934 to 3012 1 to 79       79/79
(100 %)
0 diff
(100 %id)
EC478812 Prostate .d 2944 to 3012 13 to 81       69/81
(85 %)
6 diff
(92.6 %id)
BQ186722 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2954 to 3635 1 to 682       682/684
(99 %)
2 diff
(99.8 %id)
AA357638 Prostate .d 2955 to 3179 1 to 225       225/225
(100 %)
2 diff
(99.2 %id)
EC495921 Prostate .d 2959 to 3029 77 to 5       73/77
(94 %)
0 diff
(100 %id)
EC584146 Prostate .d 2978 to 3047 10 to 78       69/81
(85 %)
3 diff
(96.3 %id)
AW411525 muscle, rhabdomyosarcoma .d 3007 to 3671 697 to 32   AAA   666/666
(100 %)
3 diff
(99.6 %id)
BM838753 lymph node, stomach .d 3009 to 3252 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
BM838675 lymph node, stomach .d 3009 to 3349 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
BU622632 cell lines, Chondrosarcoma .d 3051 to 3671 639 to 19   AAA   621/621
(100 %)
2 diff
(99.7 %id)
BQ183009 Knee, Osteoarthritic Cartilage .d 3052 to 3684 651 to 19   AAA   633/633
(100 %)
0 diff
(100 %id)
BQ181558 Knee, Osteoarthritic Cartilage .d 3054 to 3677 642 to 19   AAA   624/624
(100 %)
2 diff
(99.7 %id)
BQ003036 Chondrosarcoma, Left Pelvis .d 3129 to 3680 570 to 19   AAA   552/552
(100 %)
1 diff
(99.9 %id)
DB349217 trachea .d 3132 to 3677 546 to 1       546/546
(100 %)
0 diff
(100 %id)
BF436316 fibrotheoma, ovary .d 3156 to 3684 529 to 1       529/529
(100 %)
0 diff
(100 %id)
BE857417 brain, glioblastoma (pooled) .d 3174 to 3664 493 to 1       493/493
(100 %)
25 diff
(95.0 %id)
AV707425 adrenal gland .d 3207 to 3684 1 to 478   AAA   478/478
(100 %)
0 diff
(100 %id)
AW083114 colon, moderately differentiated adenocarcinoma .d 3235 to 3677 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI921390 adenocarcinoma, Pancreas .d 3239 to 3685 456 to 9       448/456
(98 %)
0 diff
(100 %id)
AI559576 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 3248 to 3644 416 to 18   AAA   399/399
(100 %)
4 diff
(99.0 %id)
AI432643 Kidney .d 3254 to 3684 487 to 57   AAA   431/431
(100 %)
0 diff
(100 %id)
AW129697 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 3254 to 3686 440 to 6   tiling clone,   435/440
(98 %)
0 diff
(100 %id)
AA434090   .d 3265 to 3682 419 to 4       416/419
(99 %)
0 diff
(100 %id)
BM738736 Ascites, stomach .d 3278 to 3684 1 to 407   AAA   407/407
(100 %)
0 diff
(100 %id)
AW088122 brain, tumor, 5 pooled (see description) .d 3285 to 3679 405 to 13   AAA   393/394
(99 %)
14 diff
(96.5 %id)
AW135378   .d 3285 to 3684 417 to 18   AAA   400/400
(100 %)
0 diff
(100 %id)
EC451098 Prostate .d 3287 to 3379 93 to 1       93/102
(91 %)
0 diff
(100 %id)
BF810009 colon_ins .d 3298 to 3574 276 to 1     Submitted on the opposite strand 276/276
(100 %)
1 diff
(99.7 %id)
BM789713 stomach .d 3301 to 3679 1 to 379   AAA   379/379
(100 %)
0 diff
(100 %id)
EC534011 Prostate .d 3302 to 3399 101 to 4       98/101
(97 %)
0 diff
(100 %id)
EC548315 Prostate .d 3302 to 3399 96 to 1       96/96
(100 %)
4 diff
(95.9 %id)
BM664176 eye, Retina Foveal and Macular .d 3304 to 3684 398 to 18   AAA   381/381
(100 %)
2 diff
(99.5 %id)
AA577937 bone marrow, stem cells .d 3305 to 3672 367 to 1       367/367
(100 %)
5 diff
(98.7 %id)
BF804862 colon_ins .d 3306 to 3574 1 to 268       268/268
(100 %)
4 diff
(98.6 %id)
EC567051 Prostate .d 3320 to 3417 97 to 1       97/97
(100 %)
1 diff
(99.0 %id)
EC581715 Prostate .d 3320 to 3417 98 to 1       98/98
(100 %)
0 diff
(100 %id)
BF196470 Kidney .d 3321 to 3664 345 to 1       345/345
(100 %)
3 diff
(99.2 %id)
BM795863 Ascites, stomach .d 3326 to 3684 1 to 359   AAA   359/359
(100 %)
0 diff
(100 %id)
BG958008 colon .d 3364 to 3591 230 to 3       228/231
(98 %)
0 diff
(100 %id)
BG959253 colon .d 3364 to 3618 268 to 15       254/269
(94 %)
0 diff
(100 %id)
AA437232   .d 3367 to 3685 324 to 4       321/324
(99 %)
0 diff
(100 %id)
AA853878 Bone, Hip .d 3376 to 3501 133 to 8       126/133
(94 %)
0 diff
(100 %id)
CV371729 breast .d 3398 to 3625 35 to 258       224/260
(86 %)
12 diff
(95.4 %id)
AI952737 pooled germ cell tumors .d 3404 to 3684 306 to 26   AAA   281/281
(100 %)
2 diff
(99.3 %id)
AW020932 cochlea, ear .d 3436 to 3684 1 to 249   AAA   249/249
(100 %)
5 diff
(98.0 %id)
EC496979 Prostate .d 3476 to 3578 14 to 112       99/113
(87 %)
6 diff
(94.7 %id)
AI674310 Prostate .d 3490 to 3686 225 to 30   AAA   196/196
(100 %)
9 diff
(95.5 %id)
AI653899 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 3500 to 3684 232 to 48   AAA   185/185
(100 %)
9 diff
(95.2 %id)
BX095742 ovarian tumor, ovary .d 3515 to 3685 1 to 169       169/183
(92 %)
3 diff
(98.4 %id)
H53665 ovarian tumor, ovary .d 3516 to 3684 1 to 169   fully sequenced,   169/169
(100 %)
2 diff
(98.9 %id)
AA479851 ovarian tumor, ovary .d 3517 to 3684 1 to 168   fully sequenced,   168/168
(100 %)
0 diff
(100 %id)
AA428249 ovarian tumor, ovary .d 3518 to 3684 1 to 166   fully sequenced,   166/166
(100 %)
1 diff
(99.4 %id)
AA496510 ovarian tumor, ovary .d 3541 to 3674 1 to 134       134/134
(100 %)
0 diff
(100 %id)
AW292697   .d 3554 to 3675 141 to 20       122/143
(85 %)
0 diff
(100 %id)
EC442076 Prostate .d 3570 to 3682 114 to 4       111/117
(94 %)
0 diff
(100 %id)
H53626 ovarian tumor, ovary .d 3579 to 3660 81 to 1   fully sequenced,   81/81
(100 %)
1 diff
(98.8 %id)
C01952   .d 3598 to 3684 1 to 87       87/87
(100 %)
0 diff
(100 %id)
AA477491 ovarian tumor, ovary .d 3608 to 3683 76 to 1   fully sequenced,   76/76
(100 %)
0 diff
(100 %id)
EC469094 Prostate .d 3609 to 3673 1 to 65       65/72
(90 %)
1 diff
(98.7 %id)
AA430740 ovarian tumor, ovary .d 3609 to 3685 75 to 1   fully sequenced,   75/75
(100 %)
3 diff
(96.0 %id)
BF968051 adrenal cortex carcinoma, cell line, adrenal gland .e 1 to 705 14 to 710   tiling clone,   697/815
(85 %)
14 diff
(98.3 %id)
BU543396 carcinoma, cell line, Prostate .e 450 to 1174 800 to 71   tiling clone, Submitted on the opposite strand 730/933
(78 %)
0 diff
(100 %id)
BE908252 epithelioid carcinoma, Pancreas .e 639 to 1388 1 to 745   tiling clone,   745/932
(79 %)
26 diff
(97.3 %id)
BQ229853 large cell carcinoma, lung .e 667 to 1389 7 to 736       730/867
(84 %)
21 diff
(97.6 %id)
BU185350 ductal carcinoma, cell line, Pancreas .e 724 to 1379 1 to 660       660/950
(69 %)
10 diff
(99.0 %id)
BU169023 ductal carcinoma, cell line, Pancreas .e 724 to 1467 1 to 746       746/875
(85 %)
15 diff
(98.3 %id)
BQ879489 ductal carcinoma, cell line, Pancreas .e 724 to 1445 1 to 732       732/951
(76 %)
21 diff
(97.8 %id)
BQ689708 ductal carcinoma, cell line, Pancreas .e 724 to 1550 1 to 833   tiling clone,   833/868
(95 %)
12 diff
(98.7 %id)
AU124593   .e 868 to 1723 2 to 854   tiling clone, capped   853/853
(100 %)
11 diff
(98.8 %id)
AU148420   .e 2292 to 2865 573 to 1   tiling clone,   573/574
(99 %)
13 diff
(97.8 %id)
DA128010 cerebellum .f 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
CF780677 Pooled Chondrosarcoma Tumor cells .f 521 to 1177 8 to 662   tiling clone,   655/876
(74 %)
21 diff
(97.7 %id)
DA853164 placenta .g 1 to 573 2 to 575 exact tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
CD723976 eye, lacrimal gland .h 1 to 569 3 to 573 L15X L16A A18G F19L P21T ... tiling clone,   573/573
(100 %)
3 diff
(99.5 %id)
AF312678   Gene FGFRL1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
EC463175 Prostate Gene FGFRL1, variant not shown         Suspected internal deletion, this clone was ignored    
DB317536.
matches multiple genes
brain Gene FGFRL1, variant not shown         This clone was ignored, also hits gene IDUA    
DB317536.
matches multiple genes
brain Gene IDUA, variant not shown         This clone was ignored, also hits gene IDUA    
DA527706.
matches multiple genes
brain Gene FGFRL1, variant not shown       capped This clone was ignored, also hits gene IDUA    
DA527706.
matches multiple genes
brain Gene IDUA, variant not shown       capped This clone was ignored, also hits gene IDUA    
EC582092 Prostate Gene FGFRL1, variant not shown         Suspected internal deletion, this clone was ignored    
AK172829   Gene FGFRL1, variant not shown       available from FLJ, AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
CA429575 Cell Line, Chondrosarcoma Gene FGFRL1, variant not shown       AAA This clone was ignored    
CN480681 Cell Line, Chondrosarcoma Gene FGFRL1, variant not shown       AAA This clone was ignored    
DA872243 Prostate Gene FGFRL1, variant not shown       capped This clone was ignored    
DA119598 cerebellum Gene FGFRL1, variant not shown       capped This clone was ignored    
BE793458 lung, small cell carcinoma Gene FGFRL1, variant not shown         Suspected internal deletion, this clone was ignored    
BF306936 muscle, rhabdomyosarcoma Gene FGFRL1, variant not shown         Suspected internal deletion, this clone was ignored    
BF306438 muscle, rhabdomyosarcoma Gene FGFRL1, variant not shown         Suspected internal deletion, this clone was ignored    
CD244927 White Matter Gene FGFRL1, variant not shown       AAA This clone was ignored    
TI_159696718   Gene FGFRL1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI